Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Medscape Oncology at ASCO 2025: Driving Innovation, Education & Better Patient Outcomes

    May 22, 2025 |  

    - PMLiVE

    Medscape Oncology is making a powerful impact at ASCO 2025, bringing seven high-impact symposia, new research insights, and the return of the Medscape Fellows Program—all aimed at educating the next generation of oncology professionals advancing clinical practice and improving patient outcomes 

    Fellows Program Returns—Stronger Than Ever

    The Medscape ASCO Fellows Program is back for its second year, offering hematology/oncology fellows a chance to:

    • Participate in exclusive focus groups with Medscape Oncology
    • Attend and network with expert faculty at our symposia
    • Share their ASCO experiences live from the Medscape Studio

    “We’re thrilled to bring the Fellows Program back to ASCO. This initiative not only supports the next generation of oncologists but also helps them engage in meaningful learning and connect directly with leaders in the field,” said Jelena Spyropoulos 

    If you’re passionate about advancing cancer care, Medscape Oncology at ASCO 2025 is the place to be. Join us as we deliver education that drives change—because informed clinicians mean better outcomes for patients.

    7 Symposia! Where Science Meets Practice:

    This year’s Medscape Oncology symposia go beyond the latest data—they’re designed to translate emerging science into actionable clinical strategies for real-world practice. Here’s a look at what’s in store:

    • Latest Advances in Tumor-Agnostic Strategies for NTRK Fusion-Positive Cancer: Translating Science into Clinical Practice– Explore how tumor-agnostic therapies are reshaping precision oncology through earlier detection and personalized treatment.

     

    • Myelofibrosis: Clinical Updates and Best Practices for the Community Hematology/Oncology Clinic: Updates for the Community Hematology/Oncology Clinic- Stay ahead with the latest in therapies, risk tools, and symptom management tailored for community practice.

     

    • The Gynecologic Oncology Clinic: Real-time Case Review of Patients With Endometrial or Ovarian Cancer: Walk through real patient cases with expert faculty to enhance your approach to diagnosing and treating gynecologic cancers.


    • Clinical Integration of Therapeutic Innovations in Glioma: Pathways to Improved Patient Outcomes: Explore how cutting-edge treatments are transforming glioma care—and how to apply them in practice.


    • Bispecific Antibodies in R/R FL and R/R DLBCL: Aligning on Clinical Best Practices Learn to leverage bispecific antibodies in relapsed/refractory lymphomas with emerging best practices.


    • Changing Your Practice in Squamous Cell Carcinoma of the Anal Canal: Uncover how new therapies and biomarkers are redefining standards in this underserved cancer type.


    • A Day in the Community Oncology Clinic: Exploring Molecularly Altered NSCLC: Explore real-world cases that showcase the impact of biomarker-driven treatments in NSCLC.

    Register for the symposia here

    Each session is built for clinical relevance, interactivity, and practical insights, so learners leave with tools they can apply immediately. All symposia will also be available for CME/CE credit at Medscape.org.

    Elevating Education with Data-Driven Outcomes

    Medscape Oncology will also debut three new e-publications on the ASCO website, showcasing the measurable impact of our programs on findings from a comprehensive patient survey on nonmelanoma skin cancer and breast cancer education. These publications demonstrate how education can drive real-world improvements in care.

    1. Patient perspectives on nonmelanoma skin cancer care: insights into treatment, barriers, and healthcare gaps –https://meetings.asco.org/abstracts-presentations/248219
    2. Enhancing care of patients with HR+/HER2- early breast cancer at high risk of recurrence through an expansive curriculum: real-world outcomes (RWO) a 6-month analysis https://meetings.asco.org/abstracts-presentations/244642
    3. Is increase in CME consumption associated with practice change in the real world? An empirical study among oncologists treating breast cancer https://meetings.asco.org/abstracts-presentations/248318

    Want to learn more?

    Contact Jelena Spyropoulos (jspyropoulos@medsacpe.net) for details on Medscape Oncology and our full ASCO 2025 programming.

    This content was provided by Medscape Education

    Company Details

    Medscape Logo

    Medscape Education

    Email
    Website

     Latest Content from  Medscape Education 

    Medscape Brings Impact and Data to ESPGHAN

    The ESPGHAN Congress in Milan was full of impact as Medscape Education Global presented 5 scientific posters examining the outcomes of their education. The posters detailed the impact Medscape Education...

    Empowering Nurses Through Education

    Nurse education is powerful and makes an impact.

    Pioneering Paths: Women Leadership in Rare Disease

    Rare diseases are often thought of as affecting one in 100,000 or one in 1,000,000 people, and that is true for some conditions. But there are many rare diseases that...

    TRANSFORMING CME IMPACT: MEDSCAPE’S GAME-CHANGING APPROACH

    It’s time for the CME industry to evolve. During recent years, access to data, modern technologies, and methodologies have allowed for deeper analysis of data and a better understanding of...

    Why Women in Medicine Should Embrace Social Media

    Of course social media has its downside. But online platforms are a powerful tool for women in medicine in terms of forming communities, fighting misinformation, amplifying one another, and galvanizing...

    Exceptional Impact Presented at ECCMID 2024

    The ECCMID conference in Barcelona, Spain marked the start of Medscape’s publication season in Europe. With three posters being presented at the conference, Medscape shared highlights from the powerful impact...

    Showing Deep Expertise at ONS

    The Medscape Oncology team will be connecting with the oncology nursing community this week in Washington, DC for the ONS Congress 2024.  Medscape Oncology has deep expertise in the oncology...

    MEDSCAPE’S NEW AGE OF CERTAINTY FOR CME

    The CME industry is changing. More than ever, activities need to be prioritized and measured to increase their impact on patient outcomes. Improving patient outcomes is the core objective for...

    Getting Past the Old-Fashioned View of Patient Advocacy

    Patient advocacy organizations today are data-driven, doing amazing work — and have the hard evidence to support their impact on patient care. The challenge is getting past the perception of...

    Mile High Impact at AAN 2024

    The Medscape team will be joining our neurology colleagues in Denver, CO for this year’s AAN Annual Meeting. Impact will take center stage at this year’s event as Medscape presents...